138 related articles for article (PubMed ID: 34626473)
1. Letter to the Editor From Sävendahl et al.: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".
Sävendahl L; Battelino T; Brod M; Højby Rasmussen M; Juul Kildemoes R; Saenger P
J Clin Endocrinol Metab; 2022 Jan; 107(2):e888-e889. PubMed ID: 34626473
[No Abstract] [Full Text] [Related]
2. Response to Letter to the Editor From L. Sävendahl et al: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".
Thornton PS; Maniatis AK; Aghajanova E; Chertok E; Vlachopapadopoulou E; Lin Z; Song W; Christoffersen ED; Breinholt VM; Kovalenko T; Giorgadze E; Korpal-Szczyrska M; Hofman PL; Karpf DB; Shu AD; Beckert M
J Clin Endocrinol Metab; 2022 Feb; 107(3):e1333-e1334. PubMed ID: 34626470
[No Abstract] [Full Text] [Related]
3. Response to Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".
Thornton PS; Maniatis AK; Aghajanova E; Chertok E; Lin Z; Song W; Christoffersen ED; Breinholt VM; Giorgadze E; Korpal-Szczyrska M; Hofman PL; Karpf DB; Shu AD; Beckert M
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2215-e2216. PubMed ID: 34915563
[No Abstract] [Full Text] [Related]
4. Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-naïve Children with Growth Hormone Deficiency: the Phase 3 heiGHt Trial".
Malozowski S
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2206-e2207. PubMed ID: 34918085
[No Abstract] [Full Text] [Related]
5. Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial.
Thornton PS; Maniatis AK; Aghajanova E; Chertok E; Vlachopapadopoulou E; Lin Z; Song W; Christoffersen ED; Breinholt VM; Kovalenko T; Giorgadze E; Korpal-Szczyrska M; Hofman PL; Karpf DB; Shu AD; Beckert M
J Clin Endocrinol Metab; 2021 Oct; 106(11):3184-3195. PubMed ID: 34272849
[TBL] [Abstract][Full Text] [Related]
6. Switching to Weekly Lonapegsomatropin from Daily Somatropin in Children with Growth Hormone Deficiency: The fliGHt Trial.
Maniatis AK; Nadgir U; Saenger P; Reifschneider KL; Abuzzahab J; Deeb L; Fox LA; Woods KA; Song W; Mao M; Chessler SD; Komirenko AS; Shu AD; Casella SJ; Thornton PS
Horm Res Paediatr; 2022; 95(3):233-243. PubMed ID: 35263755
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results.
Maniatis AK; Casella SJ; Nadgir UM; Hofman PL; Saenger P; Chertock ED; Aghajanova EM; Korpal-Szczyrska M; Vlachopapadopoulou E; Malievskiy O; Chaychenko T; Cappa M; Song W; Mao M; Mygind PH; Smith AR; Chessler SD; Komirenko AS; Beckert M; Shu AD; Thornton PS
J Clin Endocrinol Metab; 2022 Jun; 107(7):e2680-e2689. PubMed ID: 35428884
[TBL] [Abstract][Full Text] [Related]
8. Spotlight on Lonapegsomatropin Once-Weekly Injection and Its Potential in the Treatment of Growth Hormone Deficiency in Pediatric Patients.
Miller BS; Yuen KCJ
Drug Des Devel Ther; 2022; 16():2055-2066. PubMed ID: 35791404
[TBL] [Abstract][Full Text] [Related]
9. Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial".
Chatelain P; Kjelgaard-Hansen M; Sprogøe K
J Clin Endocrinol Metab; 2023 Jul; 108(8):e644-e645. PubMed ID: 36869710
[No Abstract] [Full Text] [Related]
10. Response to Letter to the Editor From Chatelain et al: "Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial".
Miller BS; Blair JC; Rasmussen MH; Maniatis A; Kildemoes RJ; Mori J; Polak M; Bang RB; Böttcher V; Stagi S; Horikawa R
J Clin Endocrinol Metab; 2023 Jul; 108(8):e647-e648. PubMed ID: 36869702
[No Abstract] [Full Text] [Related]
11. Optimizing growth hormone therapy in growth hormone deficient children: what to do in the absence of hard evidence? Commentary on Rachmiel et al.: Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone (Horm Res 2007;68:236-243).
Wit JM
Horm Res; 2007; 68(5):244-7. PubMed ID: 17396035
[No Abstract] [Full Text] [Related]
12. Growth hormone therapy in children with growth hormone deficiency.
Hsu HH
Acta Paediatr Taiwan; 2001; 42(5):269-70. PubMed ID: 11729701
[No Abstract] [Full Text] [Related]
13. Growth, body weight and bone maturation in children with hyposomatotrophic dwarfism under treatment with human growth hormone.
Rybak M; Soltysik-Wilk E; Drop K; Piatkowska E
Mater Med Pol; 1976; 8(1):21-5. PubMed ID: 177826
[No Abstract] [Full Text] [Related]
14. The investigation and treatment of pituitary dwarfism: preliminary experience with human growth hormone.
Burger HG; Catt K; Connelly JF; Hudson B; Martin FI; Melick R; Taft HP; Wettenhall HB
Med J Aust; 1967 Apr; 1(15):739-42. PubMed ID: 6024145
[No Abstract] [Full Text] [Related]
15. [Clinical application of growth hormone and therapeutic results in pituitary dwarfism in Japan].
Shizume K
Nihon Rinsho; 1971 Jul; 29(7):1761-7. PubMed ID: 5170119
[No Abstract] [Full Text] [Related]
16. [Treatment of hypopituitary dwarfism with human growth hormone].
Zachmann M; Prader A
Ther Umsch; 1972 Sep; 29(9):540-5. PubMed ID: 5086406
[No Abstract] [Full Text] [Related]
17. [Pituitary dwarfism. Our experience with human growth hormone treatment].
Sanz Moreno J; López-Linares M; Arrieta F; Ramos F; Herrera Pombo JL
Rev Clin Esp; 1981 Oct; 163(2):105-10. PubMed ID: 7330341
[No Abstract] [Full Text] [Related]
18. [The use of growth hormone in pediatrics in pituitary dwarfism].
Verron G
Z Gesamte Inn Med; 1968 Aug; 23(16):Suppl:252-4. PubMed ID: 5727624
[No Abstract] [Full Text] [Related]
19. Results of long-term human growth hormone therapy for pituitary dwarfism.
Shizume K; Matsuzaki F; Irie M; Osawa N
Endocrinol Jpn; 1970 Aug; 17(4):297-306. PubMed ID: 5537137
[No Abstract] [Full Text] [Related]
20. Adult height in children with growth hormone deficiency: a randomized, controlled, growth hormone dose-response trial.
Sas TC; de Ridder MA; Wit JM; Rotteveel J; Oostdijk W; Reeser HM; Otten BJ; de Muinck Keizer-Schrama SM
Horm Res Paediatr; 2010; 74(3):172-81. PubMed ID: 20424418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
